Cardionovum Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 18

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Cardionovum General Information

Description

Manufacturer of DCB & DES cardiovascular devices intended to treat coronary and vascular artery disease. The company offers coronary vascular intervention products, dilatation catheter, cobalt chromium coronary stent system and peripheral vascular intervention supplies.

Contact Information

Website
www.cardionovum.de
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Am Bonner Bogen 2
  • 53227 Bonn
  • Germany
+49 0228 0000000
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Parent Company
Shanghai Muyi Investment Management Co
Vertical(s)
Manufacturing
Corporate Office
  • Am Bonner Bogen 2
  • 53227 Bonn
  • Germany
+49 0228 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardionovum Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cardionovum‘s full profile, request access.

Request a free trial

Cardionovum Patents

  • 22

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 20

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Cardionovum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2958607-A1 Balloon surface coating Active 02-May-2013 000000000
EP-2958607-B1 Balloon surface coating Active 02-May-2013 000000000
CA-2910336-A1 Balloon surface coating comprising a water soluble shellac salt Active 02-May-2013 0000000000
ES-2592432-T3 Balloon surface coating Active 02-May-2013 000000000
US-20160082159-A1 Balloon surface coating Inactive 02-May-2013 A61L29/16 0
To view Cardionovum’s complete patent history, request access »

Cardionovum Executive Team (6)

Name Title Board Seat
Miquel Capella Chief Executive Officer
Massimo Morero Chief Technology Officer
Nicolas Euzet Finance Director & Operations
Joop Meijer Senior Vice President, Sales & Marketing
Ida Beerhalter Director, Corporate Affairs
You’re viewing 5 of 6 executive team members. Get the full list »

Cardionovum Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardionovum Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cardionovum‘s full profile, request access.

Request a free trial

Cardionovum FAQs

  • When was Cardionovum founded?

    Cardionovum was founded in 2010.

  • Who is the CEO of Cardionovum?

    Miquel Capella is the CEO of Cardionovum.

  • Where is Cardionovum headquartered?

    Cardionovum is headquartered in Bonn, Germany.

  • What is the size of Cardionovum?

    Cardionovum has 18 total employees.

  • What industry is Cardionovum in?

    Cardionovum’s primary industry is Surgical Devices.

  • Is Cardionovum a private or public company?

    Cardionovum is a Private company.

  • What is the current valuation of Cardionovum?

    The current valuation of Cardionovum is 00000.

  • What is Cardionovum’s current revenue?

    The current revenue for Cardionovum is 000000.

  • Who are Cardionovum’s investors?

    Japan Lifeline has invested in Cardionovum.

  • When was Cardionovum acquired?

    Cardionovum was acquired on 31-May-2015.

  • Who acquired Cardionovum?

    Cardionovum was acquired by Shanghai Muyi Investment Management Co.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »